CD8A and neoplasm: Recent studies with cyclophosphamide (CPA) metronomic therapy proved that this type of administration not only activates antitumour CD8+ T-cell response, but also induces long-term, specific T-cell tumour memory in GL261 tumours growing subcutaneously in immunocompetent mice [30,48].